<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for orbital lymphangioma - Patel, SR - 2019 | Cochrane Library</title> <meta content="Interventions for orbital lymphangioma - Patel, SR - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013000.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for orbital lymphangioma - Patel, SR - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013000.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013000.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for orbital lymphangioma" name="citation_title"/> <meta content="Sheel R Patel" name="citation_author"/> <meta content="Montefiore Medical Center, Albert Einstein College of Medicine" name="citation_author_institution"/> <meta content="Jamie B Rosenberg" name="citation_author"/> <meta content="Montefiore Medical Center, Albert Einstein College of Medicine" name="citation_author_institution"/> <meta content="Anne Barmettler" name="citation_author"/> <meta content="Montefiore Medical Center, Albert Einstein College of Medicine" name="citation_author_institution"/> <meta content="abarmett@montefiore.org" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD013000.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/05/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013000.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013000.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013000.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Lymphangioma [drug therapy, surgery]; *Orbital Neoplasms [drug therapy, surgery]; Antibiotics, Antineoplastic [therapeutic use]; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013000.pub2&amp;doi=10.1002/14651858.CD013000.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="8ranHhTh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013000\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013000\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fr","pl","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013000.pub2",title:"Interventions for orbital lymphangioma",firstPublishedDate:"May 15, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013000.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013000.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013000.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013000.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013000.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013000.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013000.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013000.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013000.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013000.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2294 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013000.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full#CD013000-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full#CD013000-sec-0085"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full#CD013000-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full#CD013000-sec-0039"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full#CD013000-sec-0040"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full#CD013000-sec-0067"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full#CD013000-sec-0079"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/appendices#CD013000-sec-0089"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for orbital lymphangioma</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/information#CD013000-cr-0002">Sheel R Patel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/information#CD013000-cr-0003">Jamie B Rosenberg</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013000.pub2/information#CD013000-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Anne Barmettler</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/information/en#CD013000-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 May 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013000.pub2">https://doi.org/10.1002/14651858.CD013000.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013000-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013000-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013000-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013000-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013000-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013000-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013000-abs-0001" lang="en"> <section id="CD013000-sec-0001"> <h3 class="title" id="CD013000-sec-0001">Background</h3> <p>Orbital lymphangiomas are a subset of localized vascular and lymphatic malformations, which most commonly occur in the head and neck region. Orbital lymphangiomas typically present in the first decade of life with signs of ptosis, proptosis, restriction of ocular motility, compressive optic neuropathy, and disfigurement. Therefore, early and effective treatment is crucial to preserving vision. Due to proximity to vital structures, such as the globe, optic nerve, and extraocular muscles, treatment for these lesions is complicated and includes a large array of approaches including observation, sclerotherapy, systemic therapy, and surgical excision. Of these options, there is no clear gold standard of treatment. </p> </section> <section id="CD013000-sec-0002"> <h3 class="title" id="CD013000-sec-0002">Objectives</h3> <p>To assess the evidence supporting medical and surgical interventions for the reduction/treatment of orbital lymphangiomas in children and young adults. </p> </section> <section id="CD013000-sec-0003"> <h3 class="title" id="CD013000-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2018, Issue 5); Ovid MEDLINE; Embase.com; PubMed; Latin American and Caribbean Health Sciences Literature Database (LILACS); ClinicalTrials.gov and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP). We did not use any date or language restrictions in the electronic search for trials. We last searched the electronic databases on 22 May 2018. </p> </section> <section id="CD013000-sec-0004"> <h3 class="title" id="CD013000-sec-0004">Selection criteria</h3> <p>We planned to include randomized controlled trials (RCTs) comparing at least two of the following interventions with each other for the treatment of orbital lymphangiomas: observation; sildenafil therapy; sirolimus therapy; sclerotherapy; surgery (partial or complete resection). We planned to include trials that enrolled children and adults up to 32 years of age, based on a prior clinical trial protocol. There were no restrictions regarding location or demographic factors. </p> </section> <section id="CD013000-sec-0005"> <h3 class="title" id="CD013000-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened the titles, abstracts, and full articles to assess their suitability for inclusion in this review. No risk of bias or data extraction was performed because we did not find any trials for inclusion. If there had been RCTs, two authors would have assessed the risk of bias and abstracted data independently with discrepancies being settled by consensus or consultation with a third review author. </p> </section> <section id="CD013000-sec-0006"> <h3 class="title" id="CD013000-sec-0006">Main results</h3> <p>There were no RCTs that compared any two of the mentioned interventions (medical or surgical) for treating orbital lymphangiomas in children and young adults. </p> </section> <section id="CD013000-sec-0007"> <h3 class="title" id="CD013000-sec-0007">Authors' conclusions</h3> <p>Currently, there are no published RCTs of orbital lymphangioma treatments. Without these types of studies, conclusions cannot be drawn regarding the effectiveness of the medical and surgical treatment options for patients with orbital lymphangiomas. The presence of only case reports and case series on orbital lymphangiomas makes it clear that RCTs are needed to address the differences between these options and help guide treatment plans. Such trials would ideally compare outcomes between individuals randomized to one of the following treatment options: observation, sclerotherapy, systemic sirolimus therapy, systemic sildenafil therapy, and surgical excision. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013000-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013000-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013000-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013000-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013000-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013000-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013000-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013000-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013000-abs-0004" lang="en"> <h3>Interventions for orbital lymphangioma</h3> <p><b>What is the aim of this review?</b><br/> We planned this Cochrane Review to analyze the effectiveness, recurrence rate, and side effects of the four major interventions used to treat orbital lymphangiomas including: observation (watching without intervention until the lymphangioma caused problems such as a decrease in vision or inability to close the eye); sclerotherapy (injections into the lesion that scar the lesion into a smaller size); medications taken by mouth; and surgery. The goal was to establish the relative effectiveness of treatment as measured by symptom improvement (such as droopy eyelid or swelling), decreasing lesion size, and quality of life improvement. </p> <p><b>Key messages</b><br/> Currently, there are no eligible randomized controlled trials (RCTs) comparing treatment options for orbital lymphangioma. Therefore, the effectiveness, recurrence rate, and side effects of the four major interventions used to treat orbital lymphangiomas remains uncertain. </p> <p><b>What was studied in this review?</b><br/> Lymphangiomas are localized malformations of the vascular and lymphatic system that most commonly occur in the head and neck regions of children. Lymphangiomas of the orbit (eye socket) typically present in children under the age of 16 years old with ptosis (droopy eyelid), swelling around the eye area, or with bleeding within the lesion from a minor injury. People with this condition can also present with other symptoms such as cosmetic deformity, proptosis (protrusion of the eye), restriction of eye movement (an eye that looks like it is wandering and can lead to vision loss in a child), compression of the optic nerve (a type of vision loss), and amblyopia (another type of vision loss) in children. Due to these vision‐threatening complications, early and effective treatment is crucial in preventing cosmetic disfigurement, pain, and visual impairment. </p> <p>Orbital lymphangiomas are notorious for being very difficult to treat due to how close they are to the eye and other important structures of the eye socket, all of which are needed for good vision. Treatment type also depends on lymphangioma size, cyst type, and location. One option is called observation, and this means carefully watching patients without doing any treatment. This is because some tumors are smaller or in hard‐to‐reach locations and are not threatening the vision. This may be a good option since each treatment option has side effect risks. For example, surgery can damage nearby structures, while medications by mouth can cause fever, diarrhea, headaches, and high blood pressure, amongst other problems. The option of surgery has typically been delayed until absolutely necessary as there is a high rate of the lesion growing back, there is a high risk to surrounding tissue (like the eye, the optic nerve, the eye muscles), and it is difficult to remove the entire lesion. In addition to observation and surgery, another treatment option is to inject agents called sclerosants into the lesions with the goal of reducing their size. Finally, in lesions that are difficult to access surgically or with injections, medication taken by mouth (called 'systemic medication') has also been used to reduce the size and resulting symptoms. The goal of these therapies is to reduce cosmetic disfigurement and pain caused by these lesions, in addition to avoiding vision‐threatening complications. </p> <p><b>What are the main results of the review?</b><br/> A search of the current literature and research on this topic yielded 5258 journal articles but no RCTs comparing two types of orbital lymphangioma treatments were found. Therefore no conclusions can be drawn about the effectiveness of the four major interventions of interest in treating people with orbital lymphangioma. It is clear from this review that further studies are needed that randomize people into these various treatments. Of note: there is one ongoing study that may meet these criteria, which is expected to be completed in 2021. </p> <p><b>How up to date is this review?</b><br/> The review authors searched for studies that had been published up to 22 May 2018. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013000-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013000-sec-0085"></div> <h3 class="title" id="CD013000-sec-0086">Implications for practice</h3> <section id="CD013000-sec-0086"> <p>This comprehensive examination of the literature is the first systematic review of orbital lymphangioma treatments. It exposes the lack of RCTs evaluating the effectiveness of medical and surgical treatment options for orbital lymphangioma. While the relatively low prevalence of orbital lymphangiomas and the incredibly varied presentations pose challenges to orchestrating an effective trial, developing future RCTs with the collaboration of multiple institutions will be important in creating an evidence‐based treatment paradigm. </p> <p>Based on the existing evidence and clinical practices, the most common management is to observe orbital lymphangiomas until there is a decrease in vision (whether directly or due to amblyopia), exposure keratopathy, or severe disfigurement (<a href="./references#CD013000-bbs2-0010" title="BagrodiaN , DefnetAM , KandelJJ . Management of lymphatic malformations in children. Current Opinion in Pediatrics2015;27(3):356‐63. ">Bagrodia 2015</a>; <a href="./references#CD013000-bbs2-0025" title="HonavarSG , ManjandavidaFP . Recent advances in orbital tumors‐‐a review of publications from 2014‐2016. Asia‐Pacific Journal of Ophthalmology2017;6(2):153‐8. ">Honavar 2017</a>; <a href="./references#CD013000-bbs2-0028" title="LallySE . Update on orbital lymphatic malformations. Current Opinion in Ophthalmology2016;27(5):413‐5. ">Lally 2016</a>). Then, treatment depends on size of the cysts, location, and vascular makeup. For cysts 2 cm or larger, which can be accessed via needle, sclerotherapy can be considered (<a href="./references#CD013000-bbs2-0001" title="BarnacleAM , TheodorouM , MalingSJ , Abou‐RayyahY . Sclerotherapy treatment of orbital lymphatic malformations: A large single‐centre experience. British Journal of Ophthalmology2016;100(2):204‐8. ">Barnacle 2016</a>; <a href="./references#CD013000-bbs2-0028" title="LallySE . Update on orbital lymphatic malformations. Current Opinion in Ophthalmology2016;27(5):413‐5. ">Lally 2016</a>; <a href="./references#CD013000-bbs2-0031" title="PatelKC , KalantzisG , El‐HindyN , ChangBY . Sclerotherapy for orbital lymphangioma—case series and literature review. In Vivo2017;31(2):263‐6. ">Patel 2017</a>; <a href="./references#CD013000-bbs2-0032" title="RaichuraND , AlamMS , NoronhaVO , MukherjeeB . A prospective study of the role of intralesional bleomycin in orbital lymphangioma. Journal of AAPOS2017;21(2):146‐51. ">Raichura 2017</a>). Oral sildenafil and oral sirolimus are also potentially effective treatment options, with sirolimus showing better results for those malformations with a venous component (<a href="./references#CD013000-bbs2-0009" title="AdamsDM , TrenorCC3rd , HammillAM , VinksAA , PatelMN , ChaudryG , et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics2016;137(2):e20153257. ">Adams 2016</a>; <a href="./references#CD013000-bbs2-0016" title="GandhiNG , LinLK , O'HaraM . Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmology2013;131(9):1228‐30. ">Gandhi 2013</a>; <a href="./references#CD013000-bbs2-0027" title="LagrezeWA , JoachimsenL , GrossN , TaschnerC , RosslerJ . Sirolimus‐induced regression of a large orbital lymphangioma. Orbit 2018 Feb 6 [Epub ahead of print]:1‐2. [DOI: 10.1080/01676830.2018.1436569] ">Lagreze 2018</a>; <a href="./references#CD013000-bbs2-0034" title="RussinJJ , Rangel‐CastillaL , KalaniMY , SpetzlerRF . Surgical management, outcomes, and recurrence rate of orbital lymphangiomas. Journal of Clinical Neuroscience2015;22(5):877‐82. ">Russin 2015</a>; <a href="./references#CD013000-bbs2-0007" title="SwetmanGL , BerkDR , VasanawalaSS , FeinsteinJA , LaneAT , BrucknerAL . Sildenafil for severe lymphatic malformations. New England Journal of Medicine2012;366(4):384‐6. ">Swetman 2012</a>). Surgical excision, with or without the aid of fibrin glue, is also a treatment option with the understanding that complete excision is unlikely. </p> </section> <h3 class="title" id="CD013000-sec-0087">Implications for research</h3> <section id="CD013000-sec-0087"> <p>This systematic review demonstrates the dearth of high‐level evidence in determining effectiveness of medical and surgical treatment options for orbital lymphangiomas. </p> <p>Future trials could apply a cross‐over design in which participants are randomized into treatment and non‐treatment groups, where patients can then switch to the treatment group after a certain amount of time (<a href="./references#CD013000-bbs2-0006" title="GiguèreCM , BaumanNM , SatoY , BurkeDK , GreinwaldJH , PranskyS , et al. Treatment of lymphangiomas with OK‐432 (Picibanil) sclerotherapy: a prospective multi‐institutional trial. Archives of Otolaryngology‐‐Head &amp; Neck Surgery2002; Vol. 128, issue 10:1137‐44. SmithMC , ZimmermanMB , BurkeDK , BaumanNM , SatoY , SmithRJ . Efficacy and safety of OK‐432 immunotherapy of lymphatic malformations. Laryngoscope2009;119(1):107‐115. ">Smith 2009</a>; <a href="./references#CD013000-bbs2-0008" title="JoyceTeng . Sildenafil for the treatment of lymphatic malformations. https://clinicaltrials.gov/ct2/show/NCT02335242 (first received 9 January 2015). ">Stanford 2022</a>). In these studies, outcomes measured would include reduction in radiographic size, pain levels, functional impairment due to ptosis, quality of life, ability to perform daily activities, and side effects. This method of study design would allow the measurement of the intervention treatment effect while also delivering treatment to all the patients involved in the study. Due to the rarity of this condition, its varied anatomic involvement, and its mostly pediatric patient population, RCTs may be difficult to conduct. As noted (in <a href="#CD013000-sec-0084">Agreements and disagreements with other studies or reviews</a>,) there is currently one such RCT ongoing studying sildenafil versus placebo in pediatric lymphangiomas, including the orbit. This study provides effective study design ideas for those creating an RCT for the other treatment options. Additionally, future studies would ideally include a multi‐center approach to recruit larger study populations and would also involve a multi‐disciplinary team of pediatric ophthalmologists, interventional radiologists, pediatricians, pathologists, radiologists, and oculoplastic surgeons. </p> <p>With the breadth of treatment options currently utilized, there is a significant need for well‐designed RCTs assessing the effectiveness of each treatment modality in order to best guide treatment plans for patients with orbital lymphangiomas. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013000-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013000-sec-0029"></div> <section id="CD013000-sec-0030"> <h3 class="title" id="CD013000-sec-0030">Description of the condition</h3> <p>Lymphangiomas are localized, multi‐cystic malformations of the lymphatic and vascular systems, most commonly occurring in the head and neck region of children. The prevalence of lymphangiomas has been estimated to be 1.1 to 5.3 cases per 10,000 live births, although population‐based studies including live births along with terminated pregnancies and stillbirths estimate the prevalence to be 30 cases per 10,000 (<a href="./references#CD013000-bbs2-0015" title="ForresterMB , MerzRD . Descriptive epidemiology of cystic hygroma: Hawaii, 1986 to 1999. Southern Medical Journal2004;97(7):631‐6. ">Forrester 2004</a>). Lymphangiomas represent 4% of all vascular tumors and approximately 25% of all benign pediatric vascular tumors (<a href="./references#CD013000-bbs2-0019" title="GrassoDL , PelizzoG , ZocconiE , SchleefJ . Lymphangiomas of the head and neck in children. Acta Otorhinolaryngologica Italica2008;28(1):17‐20. ">Grasso 2008</a>). Lymphangiomas involving the orbit constitute around 1% to 4% of all orbital lesions (<a href="./references#CD013000-bbs2-0029" title="NassiriN , RootmanJ , RootmanDB , GoldbergRA . Orbital lymphaticovenous malformations: current and future treatments. Survey of Ophthalmology2015;60(5):383‐405. ">Nassiri 2015</a>). In a 30‐year retrospective study of 1254 patients presenting to an ocular oncology service, Shields and colleagues found that orbital lymphangiomas accounted for 25% of all orbital vascular lesions and 4% of the total number of orbital lesions (<a href="./references#CD013000-bbs2-0036" title="ShieldsJA , ShieldsCL , ScartozziR . Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology2004;111(5):997‐1008. ">Shields 2004</a>). The rarity of orbital lymphangiomas contributes to the difficulty in determining universal treatment guidelines. </p> <p>The most frequent presenting features of orbital lymphangiomas are ptosis and proptosis with the majority of orbital lymphangiomas presenting in the first decade of life. Studies have shown that 43% of cases are diagnosed before the age of 6 years old and 60% are diagnosed before the age of 16 years, with equal distribution between males and females (<a href="./references#CD013000-bbs2-0029" title="NassiriN , RootmanJ , RootmanDB , GoldbergRA . Orbital lymphaticovenous malformations: current and future treatments. Survey of Ophthalmology2015;60(5):383‐405. ">Nassiri 2015</a>). Diagnosis tends to occur earlier for more superficial lesions and later in life for deeper lesions. The lesions can enlarge with systemic infections, typically during an upper respiratory infection or with minor trauma, which results in intralesional hemorrhage (<a href="./references#CD013000-bbs2-0026" title="KalisaP , VanZieleghemB , RouxP , MeireF . Orbital lymphangioma: clinical features and management. Bulletin de la Societe Belge d'Ophtalmologie2001;282:59‐68. ">Kalisa 2001</a>; <a href="./references#CD013000-bbs2-0032" title="RaichuraND , AlamMS , NoronhaVO , MukherjeeB . A prospective study of the role of intralesional bleomycin in orbital lymphangioma. Journal of AAPOS2017;21(2):146‐51. ">Raichura 2017</a>). Other presentations can include extraocular motility restriction, physical disfigurement, mechanical blepharoptosis (which can obstruct visual development and result in amblyopia), and compressive optic neuropathy (<a href="./references#CD013000-bbs2-0035" title="SahaK , LeatherbarrowB . Orbital lymphangiomas: a review of management strategies. Current Opinion in Ophthalmology2012;23(5):433‐8. ">Saha 2012</a>). Early and effective treatment, especially in children, is therefore crucial to preserving vision and preventing amblyopia. </p> <p>Management of orbital lymphangiomas depends heavily on understanding anatomic makeup. Orbital lymphangiomas are classified as “type 1: no flow” lesions, as per the International Orbital Society vascular malformation classification system (type 1 [no flow], type 2 [venous flow], type 3 [arterial flow] lesions). Orbital lymphangiomas have minimal internal blood flow and little to no connection with the vascular system (<a href="./references#CD013000-bbs2-0021" title="HarrisGJ . Orbital vascular malformations: a consensus statement on terminology and its clinical implications. Orbital Society. American Journal of Ophthalmology1999;127(4):453‐5. ">Harris 1999</a>). This allows for the use of sclerosant therapy, as opposed to vascular malformations with high flow or prominent connections to the vascular system, or both. </p> <p>Another important mode of classification is based on vascular lesion type, since many malformations are not just one type of vascular malformation. For example, a lesion could be made of venous and lymphatic components and the classification would be based on which entity is the most predominant (i.e. 'lymphatic dominant' vs 'venous dominant'). These distinctions can potentially predict which treatments are more effective, as seen in a study showing lymphangiomas with a venous component may respond better to oral sirolimus (<a href="./references#CD013000-bbs2-0009" title="AdamsDM , TrenorCC3rd , HammillAM , VinksAA , PatelMN , ChaudryG , et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics2016;137(2):e20153257. ">Adams 2016</a>). </p> <p>Finally, management is also dependent on depth of involvement and cyst size. More specifically, the depth categories are: </p> <p> <ul id="CD013000-list-0001"> <li> <p>superficial (presenting as a subcutaneous cyst);</p> </li> <li> <p>deep (orbital infiltration);</p> </li> <li> <p>combined (superficial and deep components);</p> </li> <li> <p>complex (intracranial or head and neck infiltration) (<a href="./references#CD013000-bbs2-0035" title="SahaK , LeatherbarrowB . Orbital lymphangiomas: a review of management strategies. Current Opinion in Ophthalmology2012;23(5):433‐8. ">Saha 2012</a>). </p> </li> </ul> </p> <p>Malformations that are superficial are easier to target with sclerotherapy and surgery, while deep, combined, or complex malformations may present more risks if a procedural approach is attempted. Cyst size also directs practicality and effectiveness of treatment. For example, there are microcysts, macrocysts (&gt; 2 cm in size), and mixed cysts (<a href="./references#CD013000-bbs2-0024" title="HillRH3rd , ShielsWE2nd , FosterJA , CzyzCN , StaceyA , EvermanKR , et al. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations. Ophthalmic Plastic and Reconstructive Surgery2012;28(2):119‐25. ">Hill 2012</a>), but typically only macrocysts are considered for sclerotherapy (<a href="./references#CD013000-bbs2-0010" title="BagrodiaN , DefnetAM , KandelJJ . Management of lymphatic malformations in children. Current Opinion in Pediatrics2015;27(3):356‐63. ">Bagrodia 2015</a>; <a href="./references#CD013000-bbs2-0020" title="HanifAM , SaundersJA , HawkinsCM , WojnoTH , KimHJ . Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations. Orbit 2018 June 14 [Epub ahead of print]:1‐7. [DOI: 10.1080/01676830.2018.1480636] ">Hanif 2018</a>). </p> <p>Lymphangioma diagnosis is best confirmed with radiologic imaging to concurrently assess size and extent. Classically, they are characterized by multiple cysts with pathognomonic fluid levels. They are isointense on T1‐weighted magnetic resonance imaging and hyperintense on T2‐weighted imaging, presenting with internal septations. As lymphangioma are classified as 'no flow' lesions, there is typically an absence of flow voids and enlarged feeder vessels (<a href="./references#CD013000-bbs2-0032" title="RaichuraND , AlamMS , NoronhaVO , MukherjeeB . A prospective study of the role of intralesional bleomycin in orbital lymphangioma. Journal of AAPOS2017;21(2):146‐51. ">Raichura 2017</a>). </p> <p>The non‐encapsulated and infiltrative nature of lymphangiomas mean that they surround vital structures of the orbit, leading to the high risk of morbidity and recurrence with many interventional treatment modalities (<a href="./references#CD013000-bbs2-0012" title="BloomDC , PerkinsJA , ManningSC . Management of lymphatic malformations. Current Opinion in Otolaryngology &amp; Head and Neck Surgery2004;12(6):500‐4. ">Bloom 2004</a>; <a href="./references#CD013000-bbs2-0032" title="RaichuraND , AlamMS , NoronhaVO , MukherjeeB . A prospective study of the role of intralesional bleomycin in orbital lymphangioma. Journal of AAPOS2017;21(2):146‐51. ">Raichura 2017</a>). </p> </section> <section id="CD013000-sec-0031"> <h3 class="title" id="CD013000-sec-0031">Description of the intervention</h3> <p>With the lack of one clear effective therapy for orbital lymphangiomas and the proximity to vital structures, such as the globe, optic nerve, and extraocular muscles, treatment for orbital lymphangiomas is complicated and includes a large array of approaches. The major interventions fall into four categories: observation (if the lesion is not causing pain, physically disfiguring, or vision threatening); intralesional sclerosant injections; systemic medication; and surgery. </p> <section id="CD013000-sec-0032"> <h4 class="title">Observation</h4> <p>Observation can be considered for patients in whom vision is not threatened and there are no significant symptoms. As complete excision is difficult with high risk of morbidity and recurrence, there are many patients and physicians who opt to monitor until any of the following occur: amblyopia; compressive optic neuropathy; exposure keratopathy; and severe cosmetic disfigurement (<a href="./references#CD013000-bbs2-0012" title="BloomDC , PerkinsJA , ManningSC . Management of lymphatic malformations. Current Opinion in Otolaryngology &amp; Head and Neck Surgery2004;12(6):500‐4. ">Bloom 2004</a>; <a href="./references#CD013000-bbs2-0035" title="SahaK , LeatherbarrowB . Orbital lymphangiomas: a review of management strategies. Current Opinion in Ophthalmology2012;23(5):433‐8. ">Saha 2012</a>). </p> </section> <section id="CD013000-sec-0033"> <h4 class="title">Sclerotherapy</h4> <p>Sclerosants have been used for the treatment of orbital lymphangiomas for the past three decades. Specific agents include OK‐432 (Picibanil), sodium tetradecyl sulfate, doxycycline, ethanol, pingyangmycin, and bleomycin (<a href="./references#CD013000-bbs2-0016" title="GandhiNG , LinLK , O'HaraM . Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmology2013;131(9):1228‐30. ">Gandhi 2013</a>). These agents are administered under ultrasound guidance by puncturing the cystic cavity, aspirating the fluid, and injecting the sclerosing agent. By aspirating the fluid, a diagnosis of the lesion can be confirmed by cytology and the surface area in contact with the agent is increased. It is important to note that sclerotherapy has been reported to be effective in treating and resolving macrocystic lymphatic malformations, with less efficacy seen in their microcystic counterparts (<a href="./references#CD013000-bbs2-0010" title="BagrodiaN , DefnetAM , KandelJJ . Management of lymphatic malformations in children. Current Opinion in Pediatrics2015;27(3):356‐63. ">Bagrodia 2015</a>). Sclerotherapy comes with risks, such as infection, bleeding, risks of damage to adjacent structures, increased orbital pressure due to the volume of injecting fluid, hemorrhage, and post‐injection reactive inflammation (<a href="./references#CD013000-bbs2-0032" title="RaichuraND , AlamMS , NoronhaVO , MukherjeeB . A prospective study of the role of intralesional bleomycin in orbital lymphangioma. Journal of AAPOS2017;21(2):146‐51. ">Raichura 2017</a>). Increased orbital pressure can result in decreased blood supply to the optic nerve and permanent vision loss. </p> </section> <section id="CD013000-sec-0034"> <h4 class="title">Systemic sildenafil</h4> <p>Systemic sildenafil therapy is a novel approach to treating lymphatic malformations that has shown positive results in both orbital and non‐orbital lymphatic lesions. It is a phosphodiesterase 5 (PDE‐5) inhibitor, which increases the levels of cyclic guanosine monophosphate in smooth muscles, leading to vasodilatory effects (<a href="./references#CD013000-bbs2-0016" title="GandhiNG , LinLK , O'HaraM . Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmology2013;131(9):1228‐30. ">Gandhi 2013</a>). Already in use in the pediatric population for pulmonary arterial hypertension, a low dose of oral sildenafil citrate has been shown to be a safe and effective method of decreasing the volume of lymphatic malformations in some children, especially those whose lesions are characterized as macrocystic or mixed (<a href="./references#CD013000-bbs2-0039" title="WangS , ZhangJ , GeW , LiuY , GuoY , LiuY , et al. Efficacy and safety of oral sildenafil in treatment of pediatric head and neck lymphatic malformations. Acta Oto‐Laryngologica2017;137(6):674‐8. ">Wang 2017</a>). Malformations have been shown to be reduced using a dose of 1 mg/kg/day of sildenafil and increasing the dose to 3 mg/kg/day, with longer‐term use (seven months) (<a href="./references#CD013000-bbs2-0016" title="GandhiNG , LinLK , O'HaraM . Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmology2013;131(9):1228‐30. ">Gandhi 2013</a>; <a href="./references#CD013000-bbs2-0039" title="WangS , ZhangJ , GeW , LiuY , GuoY , LiuY , et al. Efficacy and safety of oral sildenafil in treatment of pediatric head and neck lymphatic malformations. Acta Oto‐Laryngologica2017;137(6):674‐8. ">Wang 2017</a>). To date, no adverse events have been described (<a href="./references#CD013000-bbs2-0016" title="GandhiNG , LinLK , O'HaraM . Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmology2013;131(9):1228‐30. ">Gandhi 2013</a>). </p> </section> <section id="CD013000-sec-0035"> <h4 class="title">Systemic sirolimus</h4> <p>Sirolimus is another novel therapy for orbital lymphatic malformations. It is a target of rapamycin (mTOR), which stops the integration of signals from the PI3K/AKT pathway to coordinate proper cell growth and proliferation by regulating ribosomal biogenesis and protein synthesis. The blocking of this pathway leads to a reduction in vascular endothelial growth factor production and angiogenesis, along with a reduction in the production of cytokine IL‐2. In certain cases, sirolimus has been shown to be effective based on both radiologic evaluations and functional impairment scores. Adams and colleagues showed that sirolimus had a particularly strong response for arterial venous malformations and venous lymphatic malformations (<a href="./references#CD013000-bbs2-0009" title="AdamsDM , TrenorCC3rd , HammillAM , VinksAA , PatelMN , ChaudryG , et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics2016;137(2):e20153257. ">Adams 2016</a>). Dosing is typically 0.8 mg/m², with optimal serum trough levels of 10 ng/mL to 15 ng/mL. Monitoring is required with serum trough levels typically taken every five to seven days after initiation of treatment (<a href="./references#CD013000-bbs2-0009" title="AdamsDM , TrenorCC3rd , HammillAM , VinksAA , PatelMN , ChaudryG , et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics2016;137(2):e20153257. ">Adams 2016</a>). Systemic sirolimus does come with side effects, some of which are serious enough to limit its use in certain patients. These side effects include persistent nausea, peripheral edema, hypertriglyceridemia, fever, cold symptoms, stomach pain, and diarrhea (<a href="./references#CD013000-bbs2-0009" title="AdamsDM , TrenorCC3rd , HammillAM , VinksAA , PatelMN , ChaudryG , et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics2016;137(2):e20153257. ">Adams 2016</a>). </p> </section> <section id="CD013000-sec-0036"> <h4 class="title">Surgical excision and debulking</h4> <p>Another intervention for orbital lymphangiomas is surgical debulking. However, since lymphangiomas tend to intertwine with vital orbital structures, debulking or complete excision can damage adjacent structures (<a href="./references#CD013000-bbs2-0035" title="SahaK , LeatherbarrowB . Orbital lymphangiomas: a review of management strategies. Current Opinion in Ophthalmology2012;23(5):433‐8. ">Saha 2012</a>). In addition to risk of damage to adjacent structures, surgery comes with a significant risk of recurrence and scarring (<a href="./references#CD013000-bbs2-0031" title="PatelKC , KalantzisG , El‐HindyN , ChangBY . Sclerotherapy for orbital lymphangioma—case series and literature review. In Vivo2017;31(2):263‐6. ">Patel 2017</a>). To aid with hemostasis and surgical manipulation, surgery can be accompanied with sclerotherapy or other intralesional therapy, such as fibrin glue. Fibrin glue injected intraoperatively into the lesion allows the surgeon to have improved hemostasis and a more solid mass to mobilize and successfully excise. In severe cases, when there is an orbital lymphangioma in the posterior orbit with a blind and painful eye, orbital exenteration can be considered (<a href="./references#CD013000-bbs2-0035" title="SahaK , LeatherbarrowB . Orbital lymphangiomas: a review of management strategies. Current Opinion in Ophthalmology2012;23(5):433‐8. ">Saha 2012</a>). </p> </section> </section> <section id="CD013000-sec-0037"> <h3 class="title" id="CD013000-sec-0037">How the intervention might work</h3> <p>Due to the complicated nature of orbital lymphangiomas, the interventions described focus on reducing size and progression with the goal of eliminating pain, proptosis, amblyopia, hemorrhage, and optic neuropathy. The mechanism of action for each of these treatments is unique to the treatment. </p> <p>The mechanism of action of sclerotherapy depends on the type of medication, Sclerotherapy is an umbrella term for multiple types of medications which are injected into each cyst within the lesion, causing scarring to reduce the size of the targeted cyst (<a href="./references#CD013000-bbs2-0031" title="PatelKC , KalantzisG , El‐HindyN , ChangBY . Sclerotherapy for orbital lymphangioma—case series and literature review. In Vivo2017;31(2):263‐6. ">Patel 2017</a>). These sclerosants are classified into three types of mechanisms of action. One mechanism of action is to enhance endothelial cell death, as seen in sodium tetradecyl sulfate, ethanol, and doxycycline. Another mechanism of action by chemotherapeutic agents (like bleomycin and pingyangmycin) inhibits cell proliferation and promotes inflammatory responses that lead to cell death. Finally there are compounds, like OK‐432 for example, that promote inflammatory responses that lead to cytokine production from circulating lymphocytes. These cytokines act on the endothelium of the lymphangioma, increasing the permeability, leading to faster lymph flow and drainage and resulting shrinkage of the cystic space (<a href="./references#CD013000-bbs2-0038" title="SuzukiY , ObanaA , GohtoY , MikiT , OtukaH , InoueY . Management of orbital lymphangioma using intralesional injection of OK‐432. British Journal of Ophthalmology2000;84(6):614‐7. ">Suzuki 2000</a>). </p> <p>Another lymphangioma treatment is sildenafil, which is taken orally by the patient. Systemic sildenafil therapy reduces the size of the lesion by inhibiting PDE‐5, which is a smooth muscle relaxant. Since the cysts of lymphangiomas are thought to dilate from contraction of the muscular lining of vascular channels, sildenafil therapy is believed to reduce the size of the lesion by relaxing the smooth muscle of these vascular channels, leading to a reduction in lesion size (<a href="./references#CD013000-bbs2-0016" title="GandhiNG , LinLK , O'HaraM . Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmology2013;131(9):1228‐30. ">Gandhi 2013</a>). </p> <p>Another oral treatment for lymphangioma is sirolimus. Systemic sirolimus therapy reduces the size of the lesion through reduction in angiogenesis and cell growth. Sirolimus is a target of mTOR, leading to a disruption in the P13K/AKT pathway. Normally this pathway governs cell growth, leading to lymphangiogenesis and angiogenesis. Disorders in this pathway lead to abnormal tissue overgrowth and result in vascular anomalies (<a href="./references#CD013000-bbs2-0009" title="AdamsDM , TrenorCC3rd , HammillAM , VinksAA , PatelMN , ChaudryG , et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics2016;137(2):e20153257. ">Adams 2016</a>). In lymphangiomas, sirolimus is therefore intended to disrupt this pathway, reducing angiogenesis and cell growth, and ultimately leading to a reduction in the lesion size. </p> <p>The final treatment option in discussion is surgical debulking. Since complete surgical excision is often unsuccessful due to the intertwining nature of lymphangioma, debulking is done with the primary goal of preventing vision loss or improving cosmesis. This can be combined with non‐surgical interventions; or intraoperative fibrin glue or sclerosing agents; or both (<a href="./references#CD013000-bbs2-0035" title="SahaK , LeatherbarrowB . Orbital lymphangiomas: a review of management strategies. Current Opinion in Ophthalmology2012;23(5):433‐8. ">Saha 2012</a>). </p> </section> <section id="CD013000-sec-0038"> <h3 class="title" id="CD013000-sec-0038">Why it is important to do this review</h3> <p>Orbital lymphangiomas can lead to severe visual, cosmetic, and quality‐of‐life issues for patients. There is no consensus on the best first‐line intervention to treat this condition. Surgical resection is a challenge due to the lesion's unencapsulated nature and proximity to vital orbital structures. The difficulty and danger of excision is paired with a high recurrence rate of the lesions which can occur up to many years after initial surgery (<a href="./references#CD013000-bbs2-0034" title="RussinJJ , Rangel‐CastillaL , KalaniMY , SpetzlerRF . Surgical management, outcomes, and recurrence rate of orbital lymphangiomas. Journal of Clinical Neuroscience2015;22(5):877‐82. ">Russin 2015</a>). </p> <p>When considering alternative treatments, sclerotherapy and systemic sildenafil and sirolimus are viewed as less invasive methods to reduce lesion size. A review article that compared surgical debulking/excision to primary sclerotherapy for the treatment of head and neck lymphatic malformations suggested no difference in effectiveness one year post intervention (<a href="./references#CD013000-bbs2-0010" title="BagrodiaN , DefnetAM , KandelJJ . Management of lymphatic malformations in children. Current Opinion in Pediatrics2015;27(3):356‐63. ">Bagrodia 2015</a>). No such study exists for sildenafil and sirolimus. While the <a href="./references#CD013000-bbs2-0010" title="BagrodiaN , DefnetAM , KandelJJ . Management of lymphatic malformations in children. Current Opinion in Pediatrics2015;27(3):356‐63. ">Bagrodia 2015</a> study suggests non‐inferiority of sclerosants in head and neck lymphangiomas, this was not a randomized controlled study. There continues to be a lack of clinical consensus on the most effective treatment option. </p> <p>In this review, the aim was to examine current literature regarding each of these treatments and analyze the effectiveness, recurrence rate, and side effects of each. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013000-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013000-sec-0039"></div> <p>To assess the effectiveness of medical and surgical interventions for the reduction/treatment of orbital lymphangiomas in children and young adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013000-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013000-sec-0040"></div> <section id="CD013000-sec-0041"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013000-sec-0042"> <h4 class="title">Types of studies</h4> <p>We only considered randomized controlled trials (RCTs) for this review. There were no date or language restrictions. </p> </section> <section id="CD013000-sec-0043"> <h4 class="title">Types of participants</h4> <p>We planned to include patients if they participated in an RCT comparing at least two orbital lymphangioma managements. Patients were to be of age 32 years and below, based on the typical onset in childhood (<a href="./references#CD013000-bbs2-0030" title="NCT00975819 . Safety and efficacy study of sirolimus in complicated vascular anomalies. clinicaltrials.gov/ct2/show/study/NCT00975819 (first received 11 September 2009). ">NCT00975819</a>). There were no restrictions regarding location or demographic factors. </p> </section> <section id="CD013000-sec-0044"> <h4 class="title">Types of interventions</h4> <p>RCTs comparing at least two of the following interventions with each other for the treatment of orbital lymphangiomas. </p> <p> <ul id="CD013000-list-0002"> <li> <p>Observation.</p> </li> <li> <p>Sildenafil therapy.</p> </li> <li> <p>Sirolimus therapy.</p> </li> <li> <p>Sclerotherapy.</p> </li> <li> <p>Surgery (excision or debulking).</p> </li> </ul> </p> <p>The primary comparison of the review was surgical versus non‐surgical (sclerotherapy, sildenafil, sirolimus, or observation) therapy. Secondary comparisons included sclerotherapy versus systemic therapy (sildenafil or sirolimus) and sclerotherapy versus observation. </p> </section> <section id="CD013000-sec-0045"> <h4 class="title">Types of outcome measures</h4> <section id="CD013000-sec-0046"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome was reduction in lymphangioma size up to two years after intervention based on clinical assessment or imaging, or both. </p> </section> <section id="CD013000-sec-0047"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013000-list-0003"> <li> <p>Levels of pain post therapy (as reported by participants) up to two years after the intervention. We planned to analyze patient‐reported pain as both continuous or non‐continuous. Continuous pain measures included mean level of pain or mean change in pain, whereas non‐continuous pain measures would be analyzed as improvement, no change, and worsening. </p> </li> <li> <p>Functional impairment related to ptosis and exposure keratopathy up to two years after the intervention. We defined functional impairment as the inability to perform daily activities (as reported by participants) due to the ptosis or exposure keratopathy. Functional impairment could be reported as continuous (mean or mean change) or non‐continuous (improvement, no change, or worsening) measures. </p> </li> </ul> </p> <section id="CD013000-sec-0048"> <h6 class="title">Adverse effects</h6> <p>We planned to document and quantify any adverse effect reported in the included studies related to systemic therapy or surgery. Specific adverse effects of interest in this review included recurrence or increased size of the mass after surgery, infections following treatment, damage to surrounding orbital structures during surgery or sclerosant injection or both, increased pain, increased eyelid edema, increased pressure in the orbit due to volume of injections, and any systemic adverse effects. </p> </section> <section id="CD013000-sec-0049"> <h6 class="title">Economic data</h6> <p>We did not plan to evaluate economic data.</p> </section> <section id="CD013000-sec-0050"> <h6 class="title">Quality of life data</h6> <p>We planned to analyze quality of life scores (mean or mean change) obtained with a validated questionnaire whenever this information was available. These scores could include patient/caregiver’s satisfaction with the treatment and satisfaction with any associated cosmetic and functional changes. </p> </section> </section> </section> </section> <section id="CD013000-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013000-sec-0052"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Eyes and Vision Information Specialist searched the following electronic databases for randomized controlled trials and controlled clinical trials. There were no restrictions on language or publication year. The electronic databases were last searched on 22 May 2018. </p> <p> <ul id="CD013000-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 5) (which contains the Cochrane Eyes and Vision Trials Register) in the Cochrane Library (searched 22 May 2018) (<a href="./appendices#CD013000-sec-0090">Appendix 1</a>). </p> </li> <li> <p>MEDLINE Ovid (1946 to 22 May 2018) (<a href="./appendices#CD013000-sec-0091">Appendix 2</a>). </p> </li> <li> <p>Embase.com (1947 to 22 May 2018) (<a href="./appendices#CD013000-sec-0092">Appendix 3</a>). </p> </li> <li> <p>PubMed (1948 to 22 May 2018) (<a href="./appendices#CD013000-sec-0093">Appendix 4</a>). </p> </li> <li> <p>Latin American and Caribbean Health Sciences Literature Database (LILACS) (1982 to 22 May 2018) (<a href="./appendices#CD013000-sec-0094">Appendix 5</a>). </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 22 May 2018) (<a href="./appendices#CD013000-sec-0095">Appendix 6</a>). </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 22 May 2018) (<a href="./appendices#CD013000-sec-0096">Appendix 7</a>). </p> </li> </ul> </p> </section> <section id="CD013000-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We planned to search the reference lists of trials included in this review for additional trials of interest, in addition to the Science Citation Index, in order to find trials that cited the identified trials. </p> </section> </section> <section id="CD013000-sec-0054"> <h3 class="title" id="CD013000-sec-0054">Data collection and analysis</h3> <section id="CD013000-sec-0055"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently reviewed the abstracts and titles of articles identified through the electronic searches, using the criteria for considering studies for this review, and classified the titles and abstracts into three categories: 'definitely use,' 'possibly use,' and 'definitely exclude.' Any disagreements on classification were resolved through discussion between the two review authors. After all review authors were in agreement, the full‐text reports of studies classified as 'definitely use' and 'possibly use' were retrieved. Each review author independently assessed these reports for the inclusion criteria and classified them as 'include,' 'unsure,' and 'exclude.' We resolved any disagreements regarding study selection through discussion, and documented reasons for exclusion. All studies that met inclusion criteria would have undergone assessment of risk of bias and data extraction. </p> <p>During the selection process, no trials were eligible for inclusion in this review. The methods described below will be applicable to future updates of the review when trials eligible for inclusion have been conducted and reported. </p> </section> <section id="CD013000-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>We planned to have two review authors independently extract data regarding study design, participant characteristics, and interventions and outcomes assessed, using the data extraction forms developed by Cochrane Eyes and Vision (<a href="./appendices#CD013000-sec-0097">Appendix 8</a>). The review authors were to discuss discrepancies. If any issue were to arise with a specific study, study investigators were to contact study authors to request clarification regarding methods or missing information. One review author was to enter data into Review Manager 5 (RevMan 5) (<a href="./references#CD013000-bbs2-0033" title="Nordic Cochrane Center, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Center, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>); and a second review author was to verify the data. </p> </section> <section id="CD013000-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We planned to follow the guidelines provided in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to assess the risk of bias in included studies (<a href="./references#CD013000-bbs2-0023" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). We would have considered the following domains. </p> <p> <ul id="CD013000-list-0005"> <li> <p>Random sequence generation (selection bias).</p> </li> <li> <p>Allocation concealment; prior to randomization (selection bias).</p> </li> <li> <p>Masking (blinding) of participants and personnel (performance bias).</p> </li> <li> <p>Masking (blinding) of outcome assessors (detection bias).</p> </li> <li> <p>Incomplete outcome data (attrition bias).</p> </li> <li> <p>Selective outcome reporting (reporting bias).</p> </li> <li> <p>Other sources of bias.</p> </li> </ul> </p> <p>We planned for two review authors to independently conduct bias assessment. We would have categorized each study for each potential source of bias as at 'high', 'low', or 'unclear' risk of bias. We would have resolved any disagreements by discussion. We would have contacted study investigators when methods were reported unclearly or incompletely. </p> </section> <section id="CD013000-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>We would have categorized outcomes as either continuous or non‐continuous. For continuous outcomes, such as reduction in lymphangioma size and changes in quality of life scores, we would have calculated mean differences (MDs) and 95% confidence intervals (95% CIs) to estimate treatment effects. For non‐continuous outcomes, such as the proportion of participants with adverse effects, we would have calculated risk ratios (RRs) with 95% CIs to estimate treatment effects. We would have reported secondary outcomes of patient‐reported pain and functional impairment as continuous (mean or mean change) or non‐continuous (proportions with improvement, no change, or worsening) measures. </p> </section> <section id="CD013000-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>The primary unit of analysis was to be one eye per participant, with the unit of analysis being the participant. For any trials that included both eyes, assessment would be required to decide if appropriate analysis was used for correlated outcomes in pairs of eyes. We planned to document the study design with respect to the treatment modality and treatment of either one or both eyes, and how the correlation was handled. </p> </section> <section id="CD013000-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>In order to elucidate study reports missing outcome data, unclear study methods, outcome data, or any other information that could hinder our classification of the study for inclusion or exclusion in our review, the plan was to contact study authors. This was to be done via email with two weeks allowed for a response with the requested information. If we could not retrieve the missing information for an included study, we would then have classified the study as missing data when discussing the results. </p> </section> <section id="CD013000-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>In order to assess clinical and methodological heterogeneity, we planned to compare inclusion/exclusion criteria of included trials, characteristics of study participants, and assessments of primary and secondary outcomes. We planned to use the I² statistic (percentage) to judge statistical heterogeneity among studies included in any meta‐analysis. This statistic estimates the proportion of variation in outcome estimates due to statistical heterogeneity that cannot be attributed to random error. We would have considered an I² value over 50% to indicate substantial statistical heterogeneity (<a href="./references#CD013000-bbs2-0014" title="DeeksJJ , HigginsJPT , Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). The plan was to generate forest plots and assess them for consistency of direction and size of the effect among studies. The plan was to consider the degree of overlap in CIs among individual studies, with poor overlap of CIs indicating the presence of heterogeneity. </p> </section> <section id="CD013000-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>In order to assess reporting bias, we planned to compare outcomes reported in each included trial to the outcomes listed in the original study protocol, design report, or registry record to judge whether selective outcome reporting was likely. If a sufficient number of studies (more than 10) were included in our review for individual outcomes, the plan was to examine funnel plots for evidence of asymmetry, which may imply possible publication bias. </p> </section> <section id="CD013000-sec-0063"> <h4 class="title">Data synthesis</h4> <p>After considering the assessment of heterogeneity and the number of included trials, the plan was to perform a meta‐analysis for each outcome using either a random‐effects or fixed‐effect model. If substantial clinical or methodological heterogeneity was observed, according to the criteria detailed above, we would not have combined outcome data from individual trials in a meta‐analysis, but would, instead, have presented findings in a narrative description. When there was no evidence of clinical, statistical, or methodological heterogeneity and three or more trials were included in a meta‐analysis, our plan was to use a random‐effects model. When there was no evidence of clinical, statistical, or methodological heterogeneity and fewer than three trials were included in a meta‐analysis, our plan was to use a fixed‐effect model. </p> </section> <section id="CD013000-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not plan to conduct any subgroup analysis.</p> </section> <section id="CD013000-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>When sufficient data was available, our plan was to conduct sensitivity analysis to evaluate the effects of excluding studies deemed as at overall high risk of bias. We planned to report these findings in a tabular format. </p> <section id="CD013000-sec-0066"> <h5 class="title">Summary of findings</h5> <p>We planned to summarize findings in a table with respect to estimates of primary and secondary outcomes and adverse effects of treatments. Additionally, we planned to summarize the strengths and limitations of both primary and secondary outcome estimates. We would have assessed the certainty of the evidence to support each estimate using the GRADE approach (<a href="./references#CD013000-bbs2-0018" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version (accessed prior to 6 March 2019). Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro 2015</a>). </p> <p>We planned to report the following outcomes in 'Summary of findings' tables.</p> <p> <ul id="CD013000-list-0006"> <li> <p>Reduction in lymphangioma size (assessed up to a period of two years after the intervention).</p> </li> <li> <p>Self‐reported pain (post‐therapy, assessed up to a period of two years after the intervention).</p> </li> <li> <p>Functional impairment related to ptosis and exposure keratopathy (assessed up to two years after the intervention). </p> </li> <li> <p>Quality of life (assessed up to two years after the intervention).</p> </li> <li> <p>Adverse effects (assessed up to two years after the intervention).</p> </li> </ul> </p> <p>Potential pair‐wise comparisons included:</p> <p> <ul id="CD013000-list-0007"> <li> <p>surgical excision/debulking versus observation;</p> </li> <li> <p>surgical excision/debulking versus sildenafil;</p> </li> <li> <p>surgical excision/debulking versus sirolimus;</p> </li> <li> <p>surgical excision/debulking versus sclerotherapy;</p> </li> <li> <p>sildenafil therapy versus observation;</p> </li> <li> <p>sildenafil therapy versus sirolimus;</p> </li> <li> <p>sildenafil therapy versus sclerotherapy;</p> </li> <li> <p>sirolimus therapy versus observation;</p> </li> <li> <p>sirolimus therapy versus sclerotherapy;</p> </li> <li> <p>sclerotherapy versus observation.</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013000-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013000-sec-0067"></div> <section id="CD013000-sec-0068"> <h3 class="title">Description of studies</h3> <section id="CD013000-sec-0069"> <h4 class="title">Results of the search</h4> <p>From the electronic searches, we retrieved 5258 references to studies in May 2018 (<a href="#CD013000-fig-0001">Figure 1</a>). Of these 5258, we removed two duplicates. After examination of the titles with abstracts of these references, we excluded 5247 reports which did not match inclusion criteria or were otherwise ineligible. After exclusion, we obtained full‐text reports of the remaining nine potentially eligible reports for deeper evaluation. The review authors discussed the eligibility of these trials and resolved any disparities in opinion by consensus. We excluded eight reports of seven studies from the review, with reasons documented below. We identified one ongoing study <a href="./references#CD013000-bbs2-0008" title="JoyceTeng . Sildenafil for the treatment of lymphatic malformations. https://clinicaltrials.gov/ct2/show/NCT02335242 (first received 9 January 2015). ">Stanford 2022</a>, which will be assessed for potential inclusion in the review when data becomes available. </p> <div class="figure" id="CD013000-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013000-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013000.pub2/media/CDSR/CD013000/image_n/nCD013000-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD013000-sec-0070"> <h4 class="title">Included studies</h4> <p>No studies were eligible for inclusion in this review.</p> </section> <section id="CD013000-sec-0071"> <h4 class="title">Excluded studies</h4> <p>We excluded seven studies: four were not RCTs (<a href="./references#CD013000-bbs2-0001" title="BarnacleAM , TheodorouM , MalingSJ , Abou‐RayyahY . Sclerotherapy treatment of orbital lymphatic malformations: A large single‐centre experience. British Journal of Ophthalmology2016;100(2):204‐8. ">Barnacle 2016</a>; <a href="./references#CD013000-bbs2-0002" title="MuallemMS , GarzoziHJ . Conservative management of orbital lymphangioma. Journal of Pediatric Ophthalmology and Strabismus2000;37(1):41‐3. ">Muallem 2000</a>; <a href="./references#CD013000-bbs2-0005" title="SiresBS , GoinsCR , AndersonRL , HoldsJB . Systemic corticosteroid use in orbital lymphangioma. Ophthalmic Plastic and Reconstructive Surgery2001;17(2):85‐90. ">Sires 2001</a>; <a href="./references#CD013000-bbs2-0007" title="SwetmanGL , BerkDR , VasanawalaSS , FeinsteinJA , LaneAT , BrucknerAL . Sildenafil for severe lymphatic malformations. New England Journal of Medicine2012;366(4):384‐6. ">Swetman 2012</a>); two were not RCTs, with in addition a study population which did not include any patients with orbital lymphangiomas (<a href="./references#CD013000-bbs2-0003" title="ŞanlialpI , KarnakI , TanyelFC , SenocakME , BüyükpamukçuN . Sclerotherapy for lymphangioma in children. International Journal of Pediatric Otorhinolaryngology2003;67(7):795‐800. ">Şanlialp 2003</a>; <a href="./references#CD013000-bbs2-0004" title="ŞanlialpI , KarnakI , TanyelFC , ŞenocakME , BüyükpamukçuN . Sclerotherapy for lymphangioma in children. Pediatrik Cerrahi Dergisi2004;18(1):5‐9. ">Şanlialp 2004</a>); and one RCT was excluded as it did not include any patients with orbital lymphangiomas (<a href="./references#CD013000-bbs2-0006" title="GiguèreCM , BaumanNM , SatoY , BurkeDK , GreinwaldJH , PranskyS , et al. Treatment of lymphangiomas with OK‐432 (Picibanil) sclerotherapy: a prospective multi‐institutional trial. Archives of Otolaryngology‐‐Head &amp; Neck Surgery2002; Vol. 128, issue 10:1137‐44. SmithMC , ZimmermanMB , BurkeDK , BaumanNM , SatoY , SmithRJ . Efficacy and safety of OK‐432 immunotherapy of lymphatic malformations. Laryngoscope2009;119(1):107‐115. ">Smith 2009</a>). One study was classified as an ongoing RCT (<a href="./references#CD013000-bbs2-0008" title="JoyceTeng . Sildenafil for the treatment of lymphatic malformations. https://clinicaltrials.gov/ct2/show/NCT02335242 (first received 9 January 2015). ">Stanford 2022</a>). </p> </section> </section> <section id="CD013000-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p>No trials were eligible for inclusion in this review; therefore, risk of bias was not assessed. </p> <section id="CD013000-sec-0073"> <h4 class="title">Allocation</h4> <p>No trials were eligible for inclusion in this review; therefore, risk of bias was not assessed. </p> </section> <section id="CD013000-sec-0074"> <h4 class="title">Blinding</h4> <p>No trials were eligible for inclusion in this review; therefore, risk of bias was not assessed. </p> </section> <section id="CD013000-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>No trials were eligible for inclusion in this review; therefore, risk of bias was not assessed. </p> </section> <section id="CD013000-sec-0076"> <h4 class="title">Selective reporting</h4> <p>No trials were eligible for inclusion in this review; therefore, risk of bias was not assessed. </p> </section> <section id="CD013000-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>No trials were eligible for inclusion in this review; therefore, other potential sources of bias was not assessed. </p> </section> </section> <section id="CD013000-sec-0078"> <h3 class="title" id="CD013000-sec-0078">Effects of interventions</h3> <p>No studies were eligible for inclusion in this review; therefore, effects of interventions were not assessed. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013000-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013000-sec-0079"></div> <p>Orbital lymphangiomas, although benign, can progress to causing pain, severe globe displacement, cosmetic disfigurement, and problems with visual development and acuity in children (<a href="./references#CD013000-bbs2-0010" title="BagrodiaN , DefnetAM , KandelJJ . Management of lymphatic malformations in children. Current Opinion in Pediatrics2015;27(3):356‐63. ">Bagrodia 2015</a>; <a href="./references#CD013000-bbs2-0025" title="HonavarSG , ManjandavidaFP . Recent advances in orbital tumors‐‐a review of publications from 2014‐2016. Asia‐Pacific Journal of Ophthalmology2017;6(2):153‐8. ">Honavar 2017</a>). Orbital lymphangiomas are difficult to treat effectively and these lesions have been observed as long as possible because surgical resection is difficult with an increased risk of recurrence and damage to adjacent structures (<a href="./references#CD013000-bbs2-0031" title="PatelKC , KalantzisG , El‐HindyN , ChangBY . Sclerotherapy for orbital lymphangioma—case series and literature review. In Vivo2017;31(2):263‐6. ">Patel 2017</a>; <a href="./references#CD013000-bbs2-0035" title="SahaK , LeatherbarrowB . Orbital lymphangiomas: a review of management strategies. Current Opinion in Ophthalmology2012;23(5):433‐8. ">Saha 2012</a>). More recently, other treatment options such as intralesional sclerotherapy and systemic sildenafil or sirolimus therapy have been used with varying levels of success. There is no current consensus on the first‐line treatment for orbital lymphangiomas. A literature review from 2015 recommended that patients presenting with orbital lymphangioma should be observed first with the option of sclerotherapy for symptomatic macrocysts and surgical debulking for patients with life‐threatening disease or microcysts (<a href="./references#CD013000-bbs2-0010" title="BagrodiaN , DefnetAM , KandelJJ . Management of lymphatic malformations in children. Current Opinion in Pediatrics2015;27(3):356‐63. ">Bagrodia 2015</a>). Bagrodia and colleagues also mentioned findings regarding the efficacy of oral agents such as sildenafil and sirolimus; however the authors did not give any clinical practice recommendations due to the lack of randomized controlled trials on these agents. This Cochrane Review revealed that no RCTs met inclusion criteria; and that there is therefore a need for future RCTs to compare orbital lymphangioma treatments. </p> <section id="CD013000-sec-0080"> <h3 class="title" id="CD013000-sec-0080">Summary of main results</h3> <p>In this review, an extensive search of electronic literature databases was conducted in order to identify RCTs that evaluated the effectiveness of various medical and surgical treatment options in the management of orbital lymphangiomas. Even with this sensitive search strategy, which included over 5000 results, no RCTs met the inclusion criteria. This search highlights the need for prospective, randomized studies examining effectiveness of medical and surgical treatments for orbital lymphangiomas. </p> </section> <section id="CD013000-sec-0081"> <h3 class="title" id="CD013000-sec-0081">Overall completeness and applicability of evidence</h3> <p>Detailed below in 'Agreements and disagreements with other studies or reviews' section.</p> </section> <section id="CD013000-sec-0082"> <h3 class="title" id="CD013000-sec-0082">Quality of the evidence</h3> <p>Detailed below in 'Agreements and disagreements with other studies or reviews' section and 'Authors' conclusions' section. </p> </section> <section id="CD013000-sec-0083"> <h3 class="title" id="CD013000-sec-0083">Potential biases in the review process</h3> <p>In order to minimize any potential biases that may have arisen during the review process, the highly sensitive search for trials followed the rigorous methods and procedures as recommended by the Cochrane Eyes and Vision group. All non‐randomized studies were not included due to the high risk of bias. </p> </section> <section id="CD013000-sec-0084"> <h3 class="title" id="CD013000-sec-0084">Agreements and disagreements with other studies or reviews</h3> <p>To date, the only reviews that evaluate the effectiveness of the various medical and surgical treatment options for orbital lymphangiomas were not based on RCT evidence. The majority of evidence is low tiered: case reports, case series, retrospective studies, and interventional case series. As no RCTs have been conducted, the best evidence present today regarding the effectiveness of the various management options is of low quality, of which only two involve the orbit. </p> <p>One of these interventional case series was a prospective study of 29 patients with orbital lymphangioma (<a href="./references#CD013000-bbs2-0001" title="BarnacleAM , TheodorouM , MalingSJ , Abou‐RayyahY . Sclerotherapy treatment of orbital lymphatic malformations: A large single‐centre experience. British Journal of Ophthalmology2016;100(2):204‐8. ">Barnacle 2016</a>). All of the patients in this trial had macrocystic lymphatic malformations of the orbit and underwent sclerotherapy injection with sodium tetradecyl sulfate with an average follow‐up of 21.8 months. All patients achieved improvements in this review’s primary endpoints: a reduction in maximal lesion diameter of 50% or more, with complete radiological resolution in 51.7% (n = 15), and improvement from baseline visual acuity in 78.2% of patients. Of note: the adverse event rate was 14% (n = 1), with a patient requiring a lateral canthotomy for an intralesional hematoma that occurred 2 hours after injection. The other interventional case series examined efficacy of sclerotherapy with bleomycin injections in 13 patients with orbital lymphangiomas (<a href="https://d.docs.live.net/Users/Sheel1/Desktop/Cochrane%20Review%20Drafts/8.29%20Draft%20Interventions%20for%20orbital%20lymphangioma.htm#REF-Raichura-2017" target="_blank">Raichura 2017</a>). With a mean follow‐up of 19.69 months, there was a more than 60% reduction in maximal diameter of the lesion on MRI in 92% (n = 12) of the patients with no adverse events reported. </p> <p>These two prospective interventional studies unfortunately represent the current clinical evidence for treatment in orbital lymphangioma, but they only examine sclerotherapy. The evidence for sildenafil and sirolimus for orbital lymphangioma is based on case series only. While there are several studies on sildenafil for lymphangiomas of the neck, there are only two on sildenafil for orbital lymphangiomas specifically. One is a prospective pilot study that documented the effect of a 12‐week trial of sildenafil in two children with disabling lymphatic malformations, with one of these patients having a malformation involving the orbit (<a href="https://d.docs.live.net/Users/Sheel1/Desktop/Cochrane%20Review%20Drafts/8.29%20Draft%20Interventions%20for%20orbital%20lymphangioma.htm#STD-Swetman-2012" target="_blank">Swetman 2012</a>). The malformation in one patient was initially debulked due to risk of amblyopia and subsequently treated with sildenafil. The authors noted that within 3 weeks of treatment with sildenafil, the patient had improved opening of the affected eye (<a href="./references#CD013000-bbs2-0007" title="SwetmanGL , BerkDR , VasanawalaSS , FeinsteinJA , LaneAT , BrucknerAL . Sildenafil for severe lymphatic malformations. New England Journal of Medicine2012;366(4):384‐6. ">Swetman 2012</a>). The other study looking at oral sildenafil in orbital lymphangioma was a retrospective case series of two patients (<a href="./references#CD013000-bbs2-0016" title="GandhiNG , LinLK , O'HaraM . Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmology2013;131(9):1228‐30. ">Gandhi 2013</a>). This study noted significant reductions in the sizes of orbital lymphangiomas on oral sildenafil therapy with reduction of cheek and orbital swelling (allowing patching therapy for amblyopia) in one patient and reduction of facial swelling, lid swelling, and pain in the second patient (<a href="./references#CD013000-bbs2-0016" title="GandhiNG , LinLK , O'HaraM . Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmology2013;131(9):1228‐30. ">Gandhi 2013</a>). Of note: sildenafil has a benign side effect profile and no adverse events were observed. </p> <p>The level of evidence is similarly limited for oral sirolimus for orbital lymphangioma. There are studies showing effectivity of sirolimus in lymphangiomas in general, but only one case report of orbital lymphangioma specifically. <a href="./references#CD013000-bbs2-0027" title="LagrezeWA , JoachimsenL , GrossN , TaschnerC , RosslerJ . Sirolimus‐induced regression of a large orbital lymphangioma. Orbit 2018 Feb 6 [Epub ahead of print]:1‐2. [DOI: 10.1080/01676830.2018.1436569] ">Lagreze 2018</a> reported a case of a 23‐year‐old man, who presented with a retrobulbar microcystic lymphangioma in the right orbit that resulted in an 11 mm exophthalmos. Due to the microcystic nature of the lesion, the patient was started on oral sirolimus at 1 mg twice a day, with blood levels maintained between 5 ng/mL to 10 ng/mL for 6 months. After treatment, the lesion had clinically and radiographically regressed to an exophthalmos of 2 mm (<a href="./references#CD013000-bbs2-0027" title="LagrezeWA , JoachimsenL , GrossN , TaschnerC , RosslerJ . Sirolimus‐induced regression of a large orbital lymphangioma. Orbit 2018 Feb 6 [Epub ahead of print]:1‐2. [DOI: 10.1080/01676830.2018.1436569] ">Lagreze 2018</a>). Other studies, such as the one conducted by <a href="./references#CD013000-bbs2-0009" title="AdamsDM , TrenorCC3rd , HammillAM , VinksAA , PatelMN , ChaudryG , et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics2016;137(2):e20153257. ">Adams 2016</a>, showed partial clinical and radiologic improvements of vascular anomalies of the head and neck in children after treatment with an oral sirolimus dose of 0.8 mg twice a day for 12 courses (one course was 28 days). However, this study was not specific to orbital lymphangiomas. </p> <p>Finally, the studies available on surgical excision of orbital lymphangiomas are also limited to a few case series. <a href="./references#CD013000-bbs2-0034" title="RussinJJ , Rangel‐CastillaL , KalaniMY , SpetzlerRF . Surgical management, outcomes, and recurrence rate of orbital lymphangiomas. Journal of Clinical Neuroscience2015;22(5):877‐82. ">Russin 2015</a> assessed eight patients diagnosed with orbital lymphangioma, who underwent surgical resection of their lesions. Presenting symptoms of patients included headache, retro‐ocular pain, restriction of eye movement, diplopia, blurry vision, and proptosis. Six of the seven patients who were followed up experienced improvements in their presenting symptoms at a mean of 5.3 years. However, recurrence was seen in 5/7 (71%) of patients at a mean of 7.2 years after the initial procedure. Post‐operatively, 37.5% of patients (n = 3) had new or worsened cranial nerve defects, which resolved at the last follow‐up assessment. </p> <p>A second study on surgical excision of orbital lymphangiomas was a retrospective case of five patients by <a href="./references#CD013000-bbs2-0037" title="SimasN , FariasJP . Orbital lymphangiomas: surgical treatment and clinical outcomes. World Neurosurgery2014;81(5‐6):842 e5‐10. ">Simas 2014</a>. Pre‐operatively, all five patients had proptosis with two of the five experiencing visual acuity deficits. Computed tomography and magnetic resonance imaging showed multilobulated infiltrative lesions that occupied intra‐ and extraconal spaces. All patients underwent subtotal resection of the lesion with a pterional, lateral, or anterior superomedial approach. At a median follow up of 3.2 years, all patients had recovered from proptosis, with improvement in visual acuity in those who had presented with decreased visual acuity. During the follow‐up period, no patients presented with a recurrence of their tumor or any hemorrhagic episodes (<a href="./references#CD013000-bbs2-0037" title="SimasN , FariasJP . Orbital lymphangiomas: surgical treatment and clinical outcomes. World Neurosurgery2014;81(5‐6):842 e5‐10. ">Simas 2014</a>). Berthout and colleagues showed similar findings in a case series of two patients who underwent subtotal resection of orbital lymphangiomas with improvements in proptosis and no recurrence of hemorrhage and tumor growth at a follow‐up time of 12 months (<a href="./references#CD013000-bbs2-0011" title="BerthoutA , JacometPV , PuttermanM , GalatoireO , MoraxS . Surgical treatment of diffuse adult orbital lymphangioma: two case studies. Journal Francais d'Ophtalmologie2008;31(10):1006‐17. ">Berthout 2008</a>). </p> <p>In addition to these studies on surgical excision for orbital lymphangioma, there are two other reports of surgical excision in conjunction with fibrin glue. <a href="./references#CD013000-bbs2-0022" title="HayasakiA , NakamuraH , HamasakiT , MakinoK , YanoS , MoriokaM , et al. Successful treatment of intraorbital lymphangioma with tissue fibrin glue. Surgical Neurology2009;72(6):722‐4. ">Hayasaki 2009</a> reported a case of a 2‐year‐old girl presenting with exophthalmos and upper lid swelling, who was found to have a multilobular orbital lymphangioma. She underwent a frontal craniotomy and the cyst was punctured and drained with partial resection of the cyst wall. However, a week later, the lesion had regrown, so a secondary resection was performed with intraoperative, intralesional injection of tissue fibrin glue. After follow‐up of a few weeks, there were no signs of recurrence of the lesion in the orbit and her clinical symptoms had complete resolution (<a href="./references#CD013000-bbs2-0022" title="HayasakiA , NakamuraH , HamasakiT , MakinoK , YanoS , MoriokaM , et al. Successful treatment of intraorbital lymphangioma with tissue fibrin glue. Surgical Neurology2009;72(6):722‐4. ">Hayasaki 2009</a>). Similar results were reported in a case series of three patients who underwent surgical resection of their lymphangiomas with intralesional injection of fibrin sealant, with all cases showing improvement in their symptoms with no follow‐up complications (<a href="./references#CD013000-bbs2-0013" title="BoulosPR , Harissi‐DagherM , KavalecC , HardyI , CodereF . Intralesional injection of Tisseel fibrin glue for resection of lymphangiomas and other thin‐walled orbital cysts. Ophthalmic Plastic and Reconstructive Surgery2005;21(3):171‐6. ">Boulos 2005</a>). </p> <p>Of note: there is currently an ongoing double‐blind placebo‐controlled trial assessing the effectiveness of placebo versus oral sildenafil (20 mg) in the treatment of orbital lymphangiomas (<a href="./references#CD013000-bbs2-0008" title="JoyceTeng . Sildenafil for the treatment of lymphatic malformations. https://clinicaltrials.gov/ct2/show/NCT02335242 (first received 9 January 2015). ">Stanford 2022</a>). In this study, the investigators are assessing 40 participants, aged 6 months to 10 years old, with lymphatic malformations greater than 3 cm, confirmed by magnetic resonance imaging. Their primary outcome of interest includes a change in lesion volume within 20 weeks of treatment with the oral medication. </p> <p>While there are a number of case series and reviews, there are no published prospective RCTs comparing effectiveness and side effects of orbital lymphangioma treatments. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013000-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/media/CDSR/CD013000/urn:x-wiley:14651858:media:CD013000:CD013000-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/media/CDSR/CD013000/image_t/tCD013000-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013000-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013000.pub2/media/CDSR/CD013000/image_n/nCD013000-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/full#CD013000-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013000.pub2/media/CDSR/CD013000/image_n/nCD013000-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013000.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013000-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013000-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013000-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD013000-note-0001">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013000-note-0003">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013000-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013000\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013000\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013000\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013000\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013000\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013000.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013000.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013000.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013000.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013000.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720208585"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013000.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720208589"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013000.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dfb8e8f589377',t:'MTc0MDcyMDIwOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 